|
시장보고서
상품코드
2055351
중독 치료 시장 : 유형별, 약물 유형별, 유통 채널별, 지역별Addiction Treatment Market, By Type, By Drug Type, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
중독 치료 시장은 2026년에 106억 6,000만 달러에 달하고 2033년까지 160억 3,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 6.0%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 106억 6,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 6.00% | 시장 규모 예측(2033년) : | 160억 3,000만 달러 |
중독은 전 세계 수백만 명에게 영향을 미치는 만성적인 건강 문제입니다. 중독은 개인의 신체적, 정신적, 그리고 경제적 측면에도 영향을 미칩니다. 중독의 복잡성 때문에 회복을 촉진하기 위해서는 전문적인 치료 접근법이 필요합니다. 중독 치료 시장은 해독 및 재활부터 지속적인 관리에 이르기까지 폭넓은 서비스를 아우르고 있습니다. 신경과학의 발전으로 인해 중독에 대한 이해가 깊어졌으며, 이는 치료법에도 영향을 미치고 있습니다. 치료법은 동반된 장애나 중독의 심리적·사회적 측면에 대처할 수 있도록 점점 더 개인 맞춤형으로 발전하고 있습니다. 시장에서는 근거에 기반한 종합적인 치료법에 대한 수요가 높아지고 있습니다.
시장 역학
세계 중독 치료 시장은 중독성 물질에 대한 접근성이 용이해진 데 따른 물질 남용 장애 유병률 증가에 힘입어 성장하고 있습니다. 유엔에 따르면, 전 세계적으로 약 2억 7,100만 명이 적어도 1년에 한 번은 약물을 사용하고 있습니다. 효과적인 치료법에 대한 인식이 높아지고, 도움을 구하는 것에 대한 편견이 줄어들면서 업계 관계자들에게 성장의 기회가 열리고 있습니다. 그러나 선별 검사 및 치료 인프라의 부족과 사회적 장벽으로 인해, 개발도상국 시장의 잠재력은 여전히 비교적 미개척 상태입니다. 또한, 높은 치료비 역시 시장 성장을 어느 정도 억제하고 있습니다. 팬데믹 상황에서 약물 보조 요법에 대한 수용도가 높아지고 원격 의료 서비스가 확대됨에 따라, 시장은 이에 따른 혜택을 볼 것으로 예측됩니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적인 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표를 바탕으로 세계 중독 치료 시장의 주요 기업 프로파일을 작성했습니다. 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략.
- 본 조사에서 다루고 있는 주요 기업으로는 Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Alkremes Plc., Glenmark Pharmaceuticals, GSK plc, Johnson & Johnson Services, Inc., Novartis AG, Perrigo Company plc., Cipla, Dr. Reddy's Laboratories Limited, Hikma Pharmaceuticals Plc., Indivior Inc., Mylan N.V., Eli Lilly and Company, Tempero Bio, BioCorRx Inc., Opiant Pharmaceuticals Inc.가 있습니다.
- 본 보고서의 분석 결과는 각 기업의 마케팅 담당자 및 경영진이 향후 제품 출시, 제품 개선, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있도록 돕습니다.
- 전 세계 중독 치료 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 중독 치료 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 중독 치료 시장 : 유형별(2021-2033년)
제5장 세계의 중독 치료 시장 : 약제 유형별(2021-2033년)
제6장 세계의 중독 치료 시장 : 유통 채널별(2021-2033년)
제7장 세계의 중독 치료 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
KTH 26.06.19Addiction Treatment Market is estimated to be valued at USD 10.66 Bn in 2026 and is expected to reach USD 16.03 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 10.66 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.00% | 2033 Value Projection: | USD 16.03 Bn |
Addiction is a chronic health condition that affects millions globally. It impacts individuals physically as well as emotionally and economically. The complexity of addiction demands professional treatment approaches to facilitate recovery. The addiction treatment market encompasses a wide range of services from detoxification and rehabilitation to continuing care. Advancements in neuroscience have deepened the understanding of addiction and influenced treatment modalities. Therapies are becoming increasingly tailored to address co-occurring disorders as well as the psychological and social aspects of addiction. The market is witnessing rising demand for evidence-based and holistic treatment options.
Market Dynamics
The global addiction treatment market is driven by the rising prevalence of substance abuse disorders fueled by easy access to addictive substances. According to the United Nations, around 271 million people globally use drugs at least once a year. Increasing awareness about effective treatment options and reduced stigma associated with seeking help are creating growth opportunities for industry players. However, the market potential remains relatively untapped in developing nations due to lack of screening and treatment infrastructure as well as social barriers. High treatment costs also restrain the market growth to some extent. The market is poised to gain from the growing acceptance of medication-assisted treatment approaches and expansion of telehealth offerings during the pandemic.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global addiction treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this includes Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Alkremes Plc., Glenmark Pharmaceuticals, GSK plc, Johnson & Johnson Services, Inc., Novartis AG, Perrigo Company plc., Cipla , Dr. Reddy's Laboratories Limited, Hikma Pharmaceuticals Plc., Indivior Inc., Mylan N.V., Eli Lilly and Company, Tempero Bio, BioCorRx Inc., and Opiant Pharmaceuticals Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global addiction treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global addiction treatment market.
Market Segmentation
- By Type (Revenue, USD Bn, 2021 - 2033)
- Alcohol Addiction
- Tobacco/Nicotine Addiction
- Opioid Addiction
- Others
- By Drug Type (Revenue, USD Bn, 2021 - 2033)
- Opioids
- Buprenorphine
- Methadone
- Naltrexone
- Nicotine Replacement Therapies
- Nicotine Gums
- Nicotine Patches
- Nicotine Lozenges
- Nicotine Spray
- Non-Nicotine Medication
- Varenicline
- Bupropion
- By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Medical Stores
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Teva Pharmaceutical Industries Ltd.
- Pfizer, Inc.
- Alkremes Plc.
- Glenmark Pharmaceuticals
- GSK plc
- Johnson & Johnson Services, Inc.
- Novartis AG
- Perrigo Company plc.
- Cipla
- Reddy's Laboratories Limited
- Hikma Pharmaceuticals Plc.
- Indivior Inc.
- Mylan N.V.
- Eli Lilly and Company
- Tempero Bio
- BioCorRx Inc.
- Opiant Pharmaceuticals Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Drug Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Epidemiology
- Market Trends
- Key Developments
- Regulatory Scenario
- Manufacturer Revenue
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Addiction Treatment Market, By Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Alcohol Addiction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Tobbacco/Nicotine Addiction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Opioid Addiction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Addiction Treatment Market, By Drug Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Opioids
- Buprenorphine
- Methadone
- Naltrexone
- Nicotine Replacement Therapies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Nicotine Gums
- Nicotine Patches
- Nicotine Lozenges
- Nicotine Spray
- Non-Nicotine Medication
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Varenicline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Bupropion
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Addiction Treatment Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Medical Stores
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Addiction Treatment Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alkremes Plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Glenmark Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GSK plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Perrigo Company plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cipla
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Dr. Reddy's Laboratories Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hikma Pharmaceuticals Plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Indivior Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Tempero Bio
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BioCorRx Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Opiant Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Camurus AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
